News articles about Catasys (NASDAQ:CATS) have trended somewhat negative this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Catasys earned a daily sentiment score of -0.15 on Accern’s scale. Accern also gave news coverage about the company an impact score of 47.0900291691404 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
These are some of the media stories that may have impacted Accern Sentiment’s scoring:
- Catasys (CATS) Misses Q1 EPS by 8c, Miss on Revenues (streetinsider.com)
- Catasys’ (CATS) CEO Terren Peizer on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com)
- Catasys (CATS) Posts Quarterly Earnings Results, Meets Estimates (americanbankingnews.com)
- Catasys misses by $0.08, misses on revenue (seekingalpha.com)
- Catasys Reports 2018 First Quarter Financial Results (finance.yahoo.com)
Several analysts have recently issued reports on the stock. ValuEngine raised shares of Catasys from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd. Zacks Investment Research cut shares of Catasys from a “hold” rating to a “strong sell” rating in a research report on Friday, April 20th.
NASDAQ:CATS traded up $0.09 during mid-day trading on Monday, hitting $5.14. The stock had a trading volume of 840 shares, compared to its average volume of 50,115. The stock has a market cap of $80.36 million, a price-to-earnings ratio of -6.05 and a beta of 0.26. Catasys has a twelve month low of $3.30 and a twelve month high of $5.79.
Catasys (NASDAQ:CATS) last issued its earnings results on Tuesday, May 15th. The company reported ($0.27) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.26) by ($0.01). The firm had revenue of $1.91 million during the quarter, compared to analyst estimates of $3.00 million. Catasys had a net margin of 50.55% and a negative return on equity of 546.50%. research analysts predict that Catasys will post -0.73 EPS for the current fiscal year.
In other news, Director Michael Edward Sherman bought 15,550 shares of Catasys stock in a transaction that occurred on Tuesday, March 13th. The shares were purchased at an average price of $4.79 per share, with a total value of $74,484.50. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 92.20% of the stock is owned by company insiders.
Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.